Who We Serve

Trusted by the companies shaping life sciences

Viscadia works with companies across the life sciences industry, from emerging firms preparing their first launch to global organizations managing multi-asset portfolios. What unites our clients is the weight of the decisions they’re making, and the need for a partner who understands the commercial, clinical, and financial stakes behind the numbers.

Our role is to bring depth, discipline, and judgment to complex forecasting demands. Some come to us at the start of an asset’s life. Others come to us mid-cycle, when the questions get harder. In every case, our role is to give them a forecast they can defend and a partner they can rely on as the work evolves.

“Across multiple projects, Viscadia has listened to our needs and prioritized delivery of key insights that help us gain alignment with the broader team. Their specialization in oncology forecasting has made each forecast creation a breeze, and expanding and updating our models has been seamless. In rapidly changing therapeutic areas, Viscadia’s forecasts have withstood the test of time!”

Sarah Yue
Director, Oncology HCP Marketing, Pfizer

“I have worked with Viscadia across many companies and clients. I keep returning to them because they stay on point, grasp and incorporate changes quickly, and their team can provide a different view on market dynamics, rendering the overall output much more robust. The realism in Viscadia’s approach made it extremely easy to communicate to internal stakeholders and ultimately get traction on my projects. I cannot wait to work with them again.”

Irina Baramova
Chief Business Officer, CleanSite Medical 

“Viscadia brought additional dimensions to the existing forecast, which aided buy-in from our stakeholders. I needed someone to work alongside me, and they were the ideal partner.”

Rob Hernandez
Senior Director, Forecasting & Financial Planning, Daiichi Sankyo, Inc.

“Viscadia has been a long-term strategic partner to Milestone on the forecasting front. In addition to their responsiveness and innovative modeling techniques, they have deep therapeutic expertise which enables us to expand our own thinking and ultimately make more informed decisions.”

Josh Franklin
President, Pharmacosmos Therapeutics Inc. 

Have Questions?

Whether your seeking a career or to work with us on a project, we’re excited to chat!

Contact Us
Two women sitting at a table with laptops, engaged in conversation in an office setting.